Back to Search
Start Over
Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
- Source :
-
Bioscience reports [Biosci Rep] 2020 Oct 30; Vol. 40 (10). - Publication Year :
- 2020
-
Abstract
- Background: Increasing studies suggest that tumor immune infiltration is a relative factor of prognosis in ovarian cancer (OvCa). The present study explored the composition of tumor-infiltrating immune cells (TIICs) in OvCa using CIBERSORT algorithm and further assessed their values for prognosis and therapeutic strategies by molecular subtypes.<br />Methods: Publicly available databases including The Cancer Genome Atlas (TCGA) and GTEx were searched. Ovarian tumor samples were available from TCGA, and normal ovarian samples were obtained from the GTEx dataset. The relative proportions of immune cell profiling in OvCa and normal samples were evaluated by CIBERSORT algorithm. Association between each immune cell subtype and survival was inferred by the fractions of 22 immune cell types. "CancerSubtypes" R-package was employed to identify the three types of molecular classification and analyze the functional enrichment in each subclass. Response to immunotherapy and anticancer drug targets was predicted via TIDE algorithm and GDSC dataset.<br />Results: Substantial variation reflecting individual difference was identified between cancer and normal tissues in the immune infiltration profiles. T cells CD4 memory activated, macrophages M1 were associated with improved overall survival (OS) as evaluated by univariate Cox regression and multivariate Cox. Three subtypes were identified by ´CancerSubtypes' R-package and every sub-cluster possessed specific immune cell characterization. Meanwhile, Cluster II exhibited poor prognosis and sensitive response to immunotherapy.<br />Conclusions: The cellular component of immune infiltration shows remarkable variation in OvCa. Profiling of immune infiltration is useful in prediction of prognosis of OvCa. The results from profiling might be considered in therapeutic modulation.<br /> (© 2020 The Author(s).)
- Subjects :
- Antineoplastic Agents, Immunological pharmacology
Antineoplastic Agents, Immunological therapeutic use
CD4-Positive T-Lymphocytes immunology
Carcinoma, Ovarian Epithelial drug therapy
Carcinoma, Ovarian Epithelial immunology
Carcinoma, Ovarian Epithelial pathology
Datasets as Topic
Drug Resistance, Neoplasm immunology
Feasibility Studies
Female
Humans
Immunologic Memory
Kaplan-Meier Estimate
Lymphocyte Activation
Lymphocytes, Tumor-Infiltrating immunology
Macrophages immunology
Middle Aged
Neoplasm Invasiveness immunology
Ovarian Neoplasms drug therapy
Ovarian Neoplasms immunology
Ovarian Neoplasms pathology
Ovary cytology
Ovary pathology
Predictive Value of Tests
Prognosis
Risk Assessment methods
Survival Rate
Carcinoma, Ovarian Epithelial mortality
Immunophenotyping
Ovarian Neoplasms mortality
Ovary immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1573-4935
- Volume :
- 40
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Bioscience reports
- Publication Type :
- Academic Journal
- Accession number :
- 33043974
- Full Text :
- https://doi.org/10.1042/BSR20201431